JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Peter Zilla
Michael Wolf
Wilhelm Lichtenberg
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zilla, P.
Right arrow Articles by Franz, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zilla, P.
Right arrow Articles by Franz, T.
Related Collections
Right arrow Peripheral vascular

J Thorac Cardiovasc Surg 2008;136:717-725
© 2008 The American Association for Thoracic Surgery


Evolving Technology

Constrictive external nitinol meshes inhibit vein graft intimal hyperplasia in nonhuman primates

Peter Zilla, MD, PhDa,*, Paul Human, PhDa, Michael Wolf, BScb, Wilhelm Lichtenberg, MB ChBa, Nasser Rafiee, BScc, Deon Bezuidenhout, PhDa, Nazlia Samodien, BTechHonsa, Christian Schmidt, MDa, Thomas Franz, PhDa

a Christiaan Barnard Department of Cardiothoracic Surgery, University of Cape Town, Cape Town, South Africa
b Materials and Bioscience Center, Medtronic Inc, Minneapolis, Minn
c Medtronic Vascular, Danvers, Mass

Received for publication September 30, 2007; revisions received January 23, 2008; accepted for publication February 15, 2008.

* Address for reprints: Peter Zilla, MD, PhD, Chris Barnard Department of Cardiothoracic Surgery, University of Cape Town, 7925 Observatory, South Africa. (Email: peter.zilla{at}uct.ac.za).

Objective: External mesh support of vein grafts has been shown to mitigate the formation of intimal hyperplasia. The aim of the present study was to address the issue of optimal mesh size in a nonhuman primate model that mimics the dimensional mismatch typically encountered between clinical vein grafts and their target arteries.

Methods: The effect of mesh size on intimal hyperplasia and endothelial preservation was assessed in bilateral femoral interposition grafts in Chacma baboons (n{Sigma} = 32/n = 8 per mesh size). No mesh support (group I) was compared with external nitinol meshes at three different sizes: loose fitting (group II), 25% diameter constricting (group III), and 50% diameter constricting (group IV). Mesh sizes were seen not only in isolation but also against the background of anastomotic size mismatch at implantation, expressed as quotient of cross-sectional area of host artery to vein graft (QC).

Results: Significant amounts of intimal hyperplasia were found in group I (QC median 0.20; intimal hyperplasia 6 weeks = 1.63 ± 0.34 mm2; intimal hyperplasia 12 weeks = 1.73 ± 0.5 mm2) and group II (QC median 0.25; intimal hyperplasia 6 weeks = 1.96 ± 1.64 mm2; intimal hyperplasia 12 weeks = 2.88 ± 1.69 mm2). In contrast, group III (QC median 0.45; intimal hyperplasia 6 weeks = 0.08 ± 0.13 mm2; intimal hyperplasia 12 weeks = 0.18 ± 0.32 mm2) and IV (QC median 1.16; intimal hyperplasia 6 weeks = 0.02 ± 0.03 mm2; intimal hyperplasia 12 weeks = 0.11 ± 0.10 mm2) showed dramatically suppressed intimal hyperplasia (P < .01) at both time points. Endothelial integrity was only preserved in group IV (P < .05). There were no significant differences in vascularization and inflammation in either interlayer or intergroup comparisons.

Conclusion: By using an animal model that addressed the clinical phenomenon of diameter discrepancy between vein graft and bypassed artery, we could demonstrate that suppression of intimal hyperplasia required constrictive mesh sizes.



Abbreviations and Acronyms ANOVA = analysis of variance; BFV = baboon femoral vein; BSV = baboon lesser saphenous vein; ID = inner diameter; OD = outer diameter; QC = quotient of cross-sectional area of host artery to vein graft





This article has been cited by other articles:


Home page
Interact CardioVasc Thorac SurgHome page
J. Schoettler, J. Jussli-Melchers, C. Grothusen, L. Stracke, F. Schoeneich, S. Stohn, G. Hoffmann, and J. Cremer
Highly flexible nitinol mesh to encase aortocoronary saphenous vein grafts: first clinical experiences and angiographic results nine months postoperatively
Interact CardioVasc Thorac Surg, October 1, 2011; 13(4): 396 - 400.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
D. T. Inderbitzin, P. Matt, F. S. Eckstein, and O. Reuthebuch
eComment: External nitinol meshing of venous coronary artery bypass grafts: is safety of application really in doubt?
Interact CardioVasc Thorac Surg, October 1, 2011; 13(4): 400 - 400.
[Full Text] [PDF]


Home page
Vasc MedHome page
M. Desai, J. Mirzay-Razzaz, D. von Delft, S. Sarkar, G. Hamilton, and A. M. Seifalian
Inhibition of neointimal formation and hyperplasia in vein grafts by external stent/sheath
Vascular Medicine, August 1, 2010; 15(4): 287 - 297.
[Abstract] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
G. Rescigno, A. Angelini, A. D'Alfonso, and L. Torracca
Coronary graft use of a new external mesh support
Interact CardioVasc Thorac Surg, April 1, 2010; 10(4): 645 - 647.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Human, T. Franz, J. Scherman, L. Moodley, and P. Zilla
Dimensional analysis of human saphenous vein grafts: Implications for external mesh support.
J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1101 - 1108.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The American Association for Thoracic Surgery.